Global Disease Detection Program: Egypt
The U.S. Centers for Disease Control & Prevention (CDC) has worked with public health institutions in Egypt in collaboration with the Naval Medical Research Unit No. 3 (NAMRU-3) for over 20 years. In 2006, this collaboration broadened to leverage country and regional resources to control and combat priority infectious diseases through the establishment of a Global Disease Detection (GDD) Regional Center, in partnership with NAMRU-3. The Center utilizes NAMRU-3’s state-of-the-art laboratory facilities, including BSL-3 space, and builds on over 60 years of NAMRU-3’s successful regional public health partnerships.
In Egypt, the GDD Regional Center is coordinated by the Global Disease Detection and Response Program, one of four scientific programs within NAMRU-3. Primary partners include regional Ministries of Health, World Health Organization’s (WHO) Eastern Mediterranean Regional Office, Ford Foundation, United States Agency for International Development (USAID), Department of State, and Department of Defense/Global Emerging Infectious Disease Surveillance (DoD/ GEIS), and CDC-Atlanta. NAMRU-3 is located adjacent to the Abbassia Fever Hospital in Cairo.
Responding to Health Threats
Strong regional partnerships are in place between CDC, NAMRU-3, the Egyptian Ministry of Health, WHO, and other key public health experts. Together, partners provide vital technical assistance to detect and respond to major public health challenges, including H5N1, dengue, Rift Valley Fever, and hemorrhagic illness to over 40 countries in WHO’s Eastern Mediterranean, North and West Africa, and Central Asia regions.
NAMRU-3 is proud to have the CDC's Global Disease Detection and Response Program as one of our four scientific programs." Captain Kenneth C. Earhart, Medical Corps, United States Navy Commanding Officer, NAMRU-3
Building Disease Detection and Response Capacity
Using the International Health Regulations (2005) as an organizing framework, the Center at NAMRU-3 works to enhance global ability to develop evidence based strategies to detect and contain outbreaks at their source. This approach advances expertise in:
- Emerging infectious disease detection and response
- Field epidemiology and laboratory training
- Pandemic influenza preparedness and response
- Laboratory systems and biosafety
- Zoonotic disease research and control
- Health communications and information technology
Connecting Resources
The Center integrates surveillance and laboratory expertise to improve public health throughout the region. For instance, in 2007 during an outbreak of acute febrile illness among U.S. Army troops in Iraq, laboratory tests conducted by NAMRU-3 confirmed the presence of Sandfly fever Sicilian virus. In 2009, the Center led a NAMRU-3 and CDC effort to train over 90 epidemiologists and laboratorians from Afghanistan, Djibouti, Iraq, Egypt, Jordan, Libya, Morocco, and Sudan in epidemiology, biosafety, infection control, and laboratory science.
Making a Regional Impact
From 2007-2015, the Center at NAMRU-3 supported:
- Effective response to over 130 outbreaks at the invitation of affected countries
- Systematic surveillance for select conditions and diseases reportable within days, and sometimes hours of the occurrence
- Discovery of 12 new pathogens, including nine new to the region and one new to the world
- Establishment of laboratory diagnostic testing capacity for 62 pathogens
- Graduation of over 80 future global health leaders from five countries through the two-year Field Epidemiology Training Program (FETP)
- Participation of over 6,000 public health officials from over 30 countries in short-term pandemic response exercises and laboratory trainings
Additional Resources
Global Disease Detection Stories: Protecting the Power of Antibiotics—Lessons from Egypt
CDC Global Disease Detection (GDD) Egypt
World Antibiotic Awareness Week
CDC - Antibiotic Resistance
WHO – Global Healthcare-Associated Infections
Infographic – Antibiotic Resistance: The Global Threat
- Page last reviewed: April 4, 2016
- Page last updated: April 4, 2016
- Content source: